SUN PHARMACEUTICAL INDUSTRIES
|
|
BOM : 524715     NSE : SUNPHARMA     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
May 29,2023 |
Price(EOD): βΉ 968.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 232,276.23 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SUN PHARMACEUTICAL INDUSTRIES | 4% | -1.1% | 6.6% |
DIVIS LABORATORIES | 2.8% | 7.5% | -4.1% |
CIPLA | 2.7% | 4.6% | -2% |
DR REDDYS LABORATORIES | 2.2% | -7.4% | 4.1% |
TORRENT PHARMACEUTICALS | 0.8% | 4.6% | 31.3% |
ABBOTT INDIA | 1.8% | -1.2% | 20.3% |
ZYDUS LIFESCIENCES | 1% | -0.6% | 37.9% |
ALKEM LABORATORIES | 2.9% | -2.4% | 14.1% |
LUPIN | 3.7% | 16.1% | 29.7% |
FUNDAMENTAL ANALYSIS OF SUN PHARMACEUTICAL INDUSTRIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SUN PHARMACEUTICAL INDUSTRIES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
27.13
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 8,560.84 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] 4.15
P/B Calculated based on Book Value of Rs 55,995.40 Cr
[Latest Year - Mar2023 - Consolidated Results ] 5.29
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 43,885.70 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
6% -31% -32% |
SHARE PRICE MOMENTUM OF SUN PHARMACEUTICAL INDUSTRIES
SUN PHARMACEUTICAL INDUSTRIES vs SENSEX
DEBT OF SUN PHARMACEUTICAL INDUSTRIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.2 0.26 0.26 0.24 |
0.02 0.08 0.18 0.09 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SUN PHARMACEUTICAL INDUSTRIES
Pledged Promoter Shares |
1.78 % | |
---|---|---|
As on : Mar2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SUN PHARMACEUTICAL INDUSTRIES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-2.76% -6.71% -9.38% -7.83% |
15.71% 28.58% 207.91% 190.75% |
QtrlyTrend |
0 | |
Latest Qtr: Mar2023 | ||
Quarterly Result Analysis → |
SUN PHARMACEUTICAL INDUSTRIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MOMENTUM | 3.3% | 8.9% | 14.2% |
S&P BSE GREENEX | 2.3% | 6.4% | 12.6% |
S&P BSE HEALTHCARE | 2.2% | 3.8% | 3.8% |
S&P BSE 500 SHARIAH | 2% | 6.5% | 4.5% |
MFG | 1.9% | 4.5% | 18.6% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY PHARMA | 3.1% | 1.3% | -2.1% |
NIFTY200 MOMENTUM 30 INDEX | 2.6% | 7.2% | 16.3% |
NIFTY 100 ALPHA 30 | 2.5% | 6.3% | 0.6% |
NIFTY HEALTHCARE | 2.4% | 3.7% | 3.3% |
NIFTY 100 EQUAL WEIGHT | 2.3% | 6.5% | 11.9% |
You may also like the below Video Courses
FAQ about SUN PHARMACEUTICAL INDUSTRIES
Is SUN PHARMACEUTICAL INDUSTRIES good for long term investment?
As on May 29,2023, the Fundamentals of SUN PHARMACEUTICAL INDUSTRIES look Strong and hence it may be good for long term investment! See Financial Performance of SUN PHARMACEUTICAL INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SUN PHARMACEUTICAL INDUSTRIES UnderValued or OverValued?
As on May 29,2023, SUN PHARMACEUTICAL INDUSTRIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES ?
As on May 29,2023, the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES is Rs. 1,398.65 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 914.59
Fair Value [Median EV / Sales Model] : Rs. 1,398.65
Fair Value [Median Price / Sales Model] : Rs. 1,430.68
Estimated Median Fair Value of SUN PHARMACEUTICAL INDUSTRIES : Rs. 1,398.65
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is SUN PHARMACEUTICAL INDUSTRIES trading at a Premium or Discount?
As on May 29,2023, SUN PHARMACEUTICAL INDUSTRIES is trading at a Discount of -31% based on the estimates of Median Intrinsic Value!